4//SEC Filing
DAVIS JOHN C. JR 4
Accession 0000899243-18-018317
CIK 0001690585other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:24 PM ET
Size
7.0 KB
Accession
0000899243-18-018317
Insider Transaction Report
Form 4
DAVIS JOHN C. JR
Chief Medical Officer
Transactions
- Conversion
Common Stock
2018-06-25+8,304→ 8,304 total - Conversion
Series C Preferred Stock
2018-06-25−21,459→ 0 total→ Common Stock (8,304 underlying)
Footnotes (1)
- [F1]The Series C Preferred Stock converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Series C Preferred Stock had no expiration date.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001741287
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:24 PM ET
- Size
- 7.0 KB